However, when ovarian cancer cells were segregated based on their KRAS or PI3K (includes PIK3CA and PTEN mutations) mutational status (Fig. 1b), FK866-sensitivity (IC50) was more comparable to the most sensitive cell types (highly sensitive blood cancers (Fig. 1a)). Here, KRAS is linked to ovarian carcinoma.